Blood Adv. 2024 May 14;8(9):2148-2150. doi: 10.1182/bloodadvances.2024013112.
NO ABSTRACT
PMID:38743411 | DOI:10.1182/bloodadvances.2024013112
Spencer A, Moreau P, Mateos M-V, et al. Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX. Blood Adv. 2024;8(2):388-398
by | May 15, 2024 | Publications | 0 comments